These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25355596)

  • 1. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
    Liu W; De La Torre IG; Gutiérrez-Rivera MC; Wang B; Liu Y; Dai L; Qian W; Zhang JY
    Tumour Biol; 2015 Feb; 36(2):1307-12. PubMed ID: 25355596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
    Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
    Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
    Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
    Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
    Ye H; Sun C; Ren P; Dai L; Peng B; Wang K; Qian W; Zhang J
    Oncol Lett; 2013 Feb; 5(2):663-668. PubMed ID: 23420714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
    Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
    Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.
    Wang P; Song C; Xie W; Ye H; Wang K; Dai L; Zhang Y; Zhang J
    J Immunol Res; 2014; 2014():512540. PubMed ID: 24822225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
    Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
    Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
    Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY
    J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.
    Li L; Wang K; Dai L; Wang P; Peng XX; Zhang JY
    Mol Med Rep; 2008; 1(4):589-94. PubMed ID: 20523766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
    Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
    Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
    Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
    Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
    Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
    Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.